Lexeo Therapeutics Announces $80 Million Equity Financing
May 27 (Reuters) - Lexeo Therapeutics Inc LXEO.O:
LEXEO THERAPEUTICS ANNOUNCES $80 MILLION EQUITY FINANCING TO FURTHER ADVANCE DEVELOPMENT OF TRANSFORMATIVE GENETIC MEDICINES FOR CARDIOVASCULAR DISEASES
LEXEO THERAPEUTICS - FINANCING LED BY FRAZIER LIFE SCIENCES AND JANUS HENDERSON INVESTORS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Anthropic Revenue Surpasses OpenAI for First Time, IPO as Early as October

Meta Is About to Launch a Consumer-Facing AI Model, and OpenAI Is About to Have Its IPO, Making Now a Good Time to Buy Meta Stock

IonQ vs. Rigetti Computing: Which Quantum Computing Stock Has the Edge Now?

What company Is ASML? Between ASML and AMD, Which Is a Better Investment?

Memory Chips Drive Samsung Earnings Surge, But Stock Price Opens High and Closes Lower: Why?

Tradingkey







